Arius

Home > ... > Philosophy and Religion > Christianity > Roman Catholic and Orthodox churches: General Biographies > ...

Essential reading Compare
side-by-side The Concise Oxford Dictionary of the Christian Church The Columbia Encyclopedia, Sixth Edition

Arius

Arius , c.256-336, Libyan theologian, founder of the Arian heresy. A parish priest in Alexandria, he advanced the doctrine famous as Arianism and was excommunicated locally (321). He was declared orthodox in Asia Minor, where he had fled (323), but he was anathematized by the Council of Nicaea (see Nicaea, First Council of ) and banished by Roman Emperor Constantine (325). But in the reaction after Nicaea, he came into imperial favor. The emperor had ordered the Athanasians at Alexandria to receive him at communion when he suddenly died.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.encyclopedia.com/topic/.aspx#1E1-Arius" title="Facts and information about Arius">Arius</a>

Give this article a thumbs-up on StumbleUpon

Cite this article
Pick a style below, and copy the text for your bibliography.

MLA
Chicago
APA

"Arius." The Columbia Encyclopedia, Sixth Edition. 2008. Encyclopedia.com. 8 Dec. 2009 <http://www.encyclopedia.com>.

"Arius." The Columbia Encyclopedia, Sixth Edition. 2008. Encyclopedia.com. (December 8, 2009). http://www.encyclopedia.com/doc/1E1-Arius.html

"Arius." The Columbia Encyclopedia, Sixth Edition. 2008. Retrieved December 08, 2009 from Encyclopedia.com: http://www.encyclopedia.com/doc/1E1-Arius.html

Learn more about citation styles

Arius

The Concise Oxford Dictionary of the Christian Church | 2000 | | Â© The Concise Oxford Dictionary of the Christian Church 2000, originally published by Oxford University Press 2000. (Hide copyright information) Copyright

Arius (d. 336), heresiarch. Probably born in Libya between c.260 and 280, he was ordained in Alexandria and put in charge of one of the main churches there. About 319 he came forward as a champion of subordinationist teaching about the Person of Christ; he was condemned by a Council at Alexandria and excommunicated. The Council of Nicaea (325) also condemned him. Owing to the influence at court of Eusebius of Nicomedia, he was recalled from exile probably c.334. He died suddenly in Constantinople. See also ARIANISM.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.encyclopedia.com/topic/.aspx#1O95-Arius" title="Facts and information about Arius">Arius</a>

Cite this article
Pick a style below, and copy the text for your bibliography.

MLA
Chicago
APA

E. A. LIVINGSTONE. "Arius." The Concise Oxford Dictionary of the Christian Church. 2000. Encyclopedia.com. 8 Dec. 2009 <http://www.encyclopedia.com>.

E. A. LIVINGSTONE. "Arius." The Concise Oxford Dictionary of the Christian Church. 2000. Encyclopedia.com. (December 8, 2009). http://www.encyclopedia.com/doc/1O95-Arius.html

E. A. LIVINGSTONE. "Arius." The Concise Oxford Dictionary of the Christian Church. 2000. Retrieved December 08, 2009 from Encyclopedia.com: http://www.encyclopedia.com/doc/1O95-Arius.html

Learn more about citation styles

Related entries from encyclopedias, dictionaries and thesauruses

The Concise Oxford Dictionary of World Religions entry for Arius

Rate these entries|See all related entries

Free newspaper and magazine articles

	BioDelivery Sciences International, Inc. Announces the Closing of the Arius Pharmaceuticals Acquisition. Business Wire; 8/24/2004
	Arius Research Inc. and Goodwin Biotechnology, Inc. Sign Antibody Manufacturing Agreement. Business Wire; 7/25/2001
	Arius Sleeps with the Fishes.(Review) Newspaper article from: Cross Currents; 3/22/2001

Facts and information from other sites

Related articles from newspapers, magazines, and more

	ARIUS Research and Protein Design Labs, Inc. Sign Agreement For Expanded Collaboration. PR Newswire; 10/2/2003; 700+ words ; ARIUS Research Inc. (TSX-VE: YAR), a medical...antibodies for the potential treatment of cancer. ARIUS uses patented and proprietary processes to...kill cancer cells. Under the agreement, ARIUS will receive an upfront technology access...
	ARIUS Research Signs Anti-Cancer Antibody Discovery Deal with Takeda. PR Newswire; 4/3/2006; 700+ words ; ...April 3 /PRNewswire-FirstCall/ -- ARIUS Research Inc. (TSX-V: ARI) and Takeda...year, multi-product collaboration using ARIUS' FunctionFIRST(TM) Platform to discover...disease. Under the terms of the agreement, ARIUS will receive an upfront technology access...
	Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche. PR Newswire; 9/9/2008; 700+ words ; ...Sept. 9 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...transaction, and are recommending that ARIUS shareholders and warrant holders vote FOR...arrangement whereby Roche will acquire all of ARIUS' outstanding shares and warrants. "The...
	ARIUS Research Signs Agreement with Protein Design Labs, Inc. PR Newswire; 10/8/2002; 700+ words ; TSX Venture Exchange: YAR ARIUS Research Inc. (TSX-VE: YAR) today said that...two novel anti- cancer antibodies developed by ARIUS. During the collaborative research period, ARIUS will receive research funding. Should PDL exercise...
	ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody. PR Newswire; 1/31/2008; 700+ words ; ...Jan. 31 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...company located in Princeton, New Jersey. ARIUS' Trop-2 antibody program targets a novel...milestones and move multiple candidates from the ARIUS pipeline of drug candidates forward...
	ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody. PR Newswire; 12/5/2007; 700+ words ; ...TORONTO, Dec. 5 /PRNewswire-FirstCall/ -- ARIUS Research Inc. (TSX: ARI), a biotechnology...supply of the drug for human clinical trials which ARIUS plans to initiate in 2008. ARIUS also announced it has scheduled a pre-IND meeting...
	Arius Features Preclinical Data on Antibody Candidates at Two Conferences. PR Newswire; 9/7/2007; 700+ words ; ...Sept. 7 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...Symposium in San Francisco on September 7-8, Arius will report recent results of its antibody...the prevalence of the epitope targeted by Arius' antibody in breast cancer patients...
	ARIUS announces allowance of US patent for lead anti-cancer antibody. PR Newswire; 8/1/2007; 700+ words ; ...Aug. 1 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...antibody in the treatment of breast cancers. ARIUS now has 16 issued and allowed patents covering...2 antibody drug is in development by ARIUS for breast, prostate and liver cancers...
	ARIUS to Present at BIO Emerging Company Investor Forum. PR Newswire; 10/13/2004; 700+ words ; ...Functional Antibody TSX Venture Exchange: ARI ARIUS Research Inc. (TSX-V: ARI) has been...President and Chief Scientific Officer of ARIUS, will provide an overview of the company...Hotel. The presentation will focus on ARIUS' proprietary FunctionFIRST(TM) discovery...
	ARIUS Announces Changes to Board of Directors. PR Newswire; 12/6/2007; 700+ words ; ...Dec. 6 /PRNewswire-FirstCall/ -- ARIUS Research Inc., (TSX: ARI), a biotechnology...Rae will be a valuable addition to the ARIUS Board of Directors," said Dr. David...President and Chief Executive Officer of ARIUS. "Furthermore, his experience in strategic...